SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.900-4.3%Dec 19 3:54 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AgAuUSA who wrote (9583)7/1/1998 1:48:00 PM
From: dowman  Read Replies (1) of 14328
 
My information is correct. Call Sanofi, who holds the patent, or JNJ or ABT who hold the license. Or for that matter, call people involved in this issue such as the FDA or someone at the CDC and ask them. Or for that matter call others that would love to hold the license and I know are trying to obtain the license such as Calypte or Epitope. You made up your mind in the eighties, but things have changed. You can never learn anything new by seeking out those who already agree with you. This is a huge issue for approval unless the FDA changes their position. I have seen it posted hear that the last conference call disclosed that the company did not expect approval for the test this year. This is the reason
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News